These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8568462)

  • 1. Opioid receptor activation resets the hypothalamic clock generating growth hormone secretory bursts in the rat.
    Willoughby JO; Medvedev A
    J Endocrinol; 1996 Jan; 148(1):149-55. PubMed ID: 8568462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
    Leshin LS; Rund LA; Thompson FN; Mahaffey MB; Chang WJ; Byerley DJ; Kiser TE
    J Anim Sci; 1990 Jun; 68(6):1656-65. PubMed ID: 2384365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic stimulation or antagonism of opiate receptors on GH secretion in male and female rats.
    Simpkins JW; Millard WJ; Berglund LA
    Life Sci; 1993; 52(17):1443-50. PubMed ID: 8385257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI; Mayfield MA; McCann SM; Krulich L
    Life Sci; 1984 May; 34(19):1829-37. PubMed ID: 6330479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory bursts of growth hormone secretion in the dog may be initiated by somatostatin withdrawal.
    Cowan JS; Gaul P; Moor BC; Kraicer J
    Can J Physiol Pharmacol; 1984 Feb; 62(2):199-207. PubMed ID: 6143604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
    Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
    J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.
    van den Berg G; Veldhuis JD; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2460-7. PubMed ID: 8675561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intravenous administration.
    Chapman IM; Willoughby JO
    Neuroendocrinology; 1993 May; 57(5):912-20. PubMed ID: 8105397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of gamma-aminobutyric acid in growth hormone release induced by a Met5-enkephalin analog in conscious rats.
    Katakami H; Kato Y; Matsushita N; Shimatsu A; Imura H
    Endocrinology; 1981 Oct; 109(4):1033-6. PubMed ID: 7285858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of hypothalamic somatostatin in glucagon-induced suppression of growth hormone secretion in conscious rats.
    Katakami H; Kato Y; Matsushita N; Shimatsu A; Imura H
    Peptides; 1983; 4(6):849-52. PubMed ID: 6143299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men.
    Hartman ML; Veldhuis JD; Johnson ML; Lee MM; Alberti KG; Samojlik E; Thorner MO
    J Clin Endocrinol Metab; 1992 Apr; 74(4):757-65. PubMed ID: 1548337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of rat GH but not human IGF-I into a defined area of the hypothalamus inhibits endogenous GH secretion in rats.
    Minami S; Suzuki N; Sugihara H; Tamura H; Emoto N; Wakabayashi I
    J Endocrinol; 1997 May; 153(2):283-90. PubMed ID: 9166118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E1 in conscious male rats.
    Katakami H; Kato Y; Matsushita N; Imura H
    Neuroendocrinology; 1984 Jan; 38(1):1-5. PubMed ID: 6320028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
    Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
    J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate inhibition of growth hormone secretion in young chickens.
    Harvey S; Scanes CG
    Gen Comp Endocrinol; 1987 Jan; 65(1):34-9. PubMed ID: 3803900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig.
    Giri M; Kaufman JM
    Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.